In BLM-induced rats, WYLG granules significantly alleviated pulmonary fibrosis, reduced inflammatory cell infiltration and collagen deposition, downregulated IL-6 and α-SMA levels, and upregulated E-cadherin expression. The gene discussed is ACTA1; the disease is pulmonary fibrosis.